 Theodore Randolph
Concepts (504)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Monoclonal | 34 | 2022 | 1270 | 7.090 |
Why?
| | Protein Aggregates | 25 | 2022 | 65 | 5.710 |
Why?
| | Silicone Oils | 15 | 2017 | 26 | 4.720 |
Why?
| | Proteins | 32 | 2022 | 912 | 4.330 |
Why?
| | Recombinant Proteins | 51 | 2019 | 1233 | 4.220 |
Why?
| | Freeze Drying | 42 | 2021 | 75 | 4.200 |
Why?
| | Chemistry, Pharmaceutical | 35 | 2021 | 98 | 4.160 |
Why?
| | Particle Size | 39 | 2022 | 317 | 4.040 |
Why?
| | Drug Stability | 50 | 2021 | 151 | 3.350 |
Why?
| | Immunoglobulin G | 24 | 2020 | 776 | 3.310 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 14 | 2019 | 254 | 3.130 |
Why?
| | Antibody Formation | 13 | 2017 | 267 | 3.070 |
Why?
| | Ebolavirus | 4 | 2022 | 34 | 2.900 |
Why?
| | Excipients | 28 | 2019 | 49 | 2.680 |
Why?
| | Immunoglobulins, Intravenous | 9 | 2021 | 122 | 2.640 |
Why?
| | Drug Compounding | 18 | 2022 | 89 | 2.560 |
Why?
| | Human Growth Hormone | 9 | 2014 | 38 | 2.400 |
Why?
| | Surface-Active Agents | 18 | 2020 | 79 | 2.390 |
Why?
| | Muramidase | 12 | 2022 | 72 | 2.150 |
Why?
| | Aluminum Hydroxide | 8 | 2019 | 12 | 2.150 |
Why?
| | Nanoparticles | 10 | 2020 | 313 | 2.130 |
Why?
| | Water | 23 | 2022 | 399 | 2.130 |
Why?
| | Hemorrhagic Fever, Ebola | 3 | 2021 | 33 | 2.090 |
Why?
| | Adjuvants, Immunologic | 10 | 2022 | 206 | 2.050 |
Why?
| | Polysorbates | 22 | 2022 | 35 | 1.960 |
Why?
| | Growth Hormone | 6 | 2016 | 103 | 1.950 |
Why?
| | Protein Folding | 32 | 2012 | 239 | 1.900 |
Why?
| | Adsorption | 22 | 2020 | 119 | 1.900 |
Why?
| | Vaccines | 4 | 2022 | 376 | 1.790 |
Why?
| | Protein Conformation | 40 | 2017 | 811 | 1.750 |
Why?
| | Papillomavirus Vaccines | 3 | 2023 | 223 | 1.700 |
Why?
| | Protein Stability | 29 | 2020 | 157 | 1.640 |
Why?
| | Syringes | 8 | 2019 | 41 | 1.600 |
Why?
| | Viral Vaccines | 3 | 2022 | 89 | 1.570 |
Why?
| | Machine Learning | 4 | 2022 | 318 | 1.510 |
Why?
| | Antibodies | 4 | 2021 | 372 | 1.460 |
Why?
| | Drug Packaging | 6 | 2020 | 43 | 1.400 |
Why?
| | Technology, Pharmaceutical | 7 | 2015 | 19 | 1.370 |
Why?
| | Sucrose | 20 | 2019 | 91 | 1.300 |
Why?
| | Stress, Mechanical | 10 | 2023 | 447 | 1.300 |
Why?
| | Papillomavirus Infections | 2 | 2023 | 262 | 1.280 |
Why?
| | Glass | 7 | 2019 | 42 | 1.260 |
Why?
| | Immunoconjugates | 5 | 2019 | 87 | 1.250 |
Why?
| | Microspheres | 6 | 2016 | 123 | 1.210 |
Why?
| | Mice, Inbred BALB C | 14 | 2021 | 1153 | 1.190 |
Why?
| | Trehalose | 11 | 2022 | 30 | 1.160 |
Why?
| | Microscopy | 5 | 2022 | 125 | 1.140 |
Why?
| | Freezing | 17 | 2019 | 85 | 1.130 |
Why?
| | Adjuvants, Pharmaceutic | 4 | 2022 | 10 | 1.130 |
Why?
| | Complement Activation | 2 | 2019 | 340 | 1.100 |
Why?
| | Emulsions | 6 | 2022 | 42 | 1.100 |
Why?
| | Thermodynamics | 24 | 2009 | 383 | 0.980 |
Why?
| | Glycoproteins | 3 | 2022 | 305 | 0.980 |
Why?
| | Serum Albumin | 5 | 2015 | 134 | 0.970 |
Why?
| | Amyloid | 6 | 2021 | 80 | 0.960 |
Why?
| | Temperature | 24 | 2021 | 576 | 0.940 |
Why?
| | Solubility | 17 | 2019 | 224 | 0.940 |
Why?
| | Virion | 2 | 2023 | 73 | 0.910 |
Why?
| | Chromatography, Gel | 15 | 2016 | 125 | 0.880 |
Why?
| | Immunologic Factors | 2 | 2019 | 221 | 0.870 |
Why?
| | Capsid | 1 | 2023 | 75 | 0.870 |
Why?
| | Drug Contamination | 7 | 2019 | 53 | 0.860 |
Why?
| | Mice | 26 | 2023 | 14936 | 0.860 |
Why?
| | Colloids | 7 | 2018 | 56 | 0.850 |
Why?
| | Protein Interaction Mapping | 2 | 2016 | 101 | 0.850 |
Why?
| | Root Cause Analysis | 1 | 2022 | 8 | 0.840 |
Why?
| | Inclusion Bodies | 4 | 2010 | 24 | 0.810 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2022 | 686 | 0.790 |
Why?
| | Capsid Proteins | 3 | 2021 | 69 | 0.780 |
Why?
| | Hydrogen-Ion Concentration | 19 | 2013 | 512 | 0.770 |
Why?
| | Surface Properties | 18 | 2019 | 387 | 0.760 |
Why?
| | Alphapapillomavirus | 1 | 2021 | 36 | 0.760 |
Why?
| | Bacteriophage lambda | 1 | 2022 | 81 | 0.750 |
Why?
| | Animals | 44 | 2023 | 31839 | 0.740 |
Why?
| | Protein Structure, Secondary | 19 | 2014 | 325 | 0.730 |
Why?
| | Marburgvirus | 1 | 2020 | 10 | 0.730 |
Why?
| | Granulocyte Colony-Stimulating Factor | 4 | 2012 | 71 | 0.720 |
Why?
| | Recombinant Fusion Proteins | 5 | 2012 | 617 | 0.720 |
Why?
| | Biotechnology | 3 | 2010 | 41 | 0.720 |
Why?
| | Spectrometry, Fluorescence | 10 | 2021 | 157 | 0.710 |
Why?
| | Hydrostatic Pressure | 8 | 2011 | 19 | 0.710 |
Why?
| | Benzyl Alcohol | 6 | 2011 | 11 | 0.700 |
Why?
| | Fluorescent Dyes | 3 | 2018 | 300 | 0.700 |
Why?
| | Gels | 3 | 2016 | 72 | 0.680 |
Why?
| | Polyvinyl Chloride | 1 | 2019 | 5 | 0.670 |
Why?
| | Drug Storage | 14 | 2021 | 59 | 0.660 |
Why?
| | Diethylhexyl Phthalate | 1 | 2019 | 9 | 0.660 |
Why?
| | Sialoglycoproteins | 5 | 2006 | 158 | 0.660 |
Why?
| | Ebola Vaccines | 1 | 2019 | 4 | 0.650 |
Why?
| | Insulin | 3 | 2021 | 2079 | 0.640 |
Why?
| | Benzothiazoles | 2 | 2018 | 33 | 0.620 |
Why?
| | Osmolar Concentration | 9 | 2016 | 174 | 0.610 |
Why?
| | Hemoglobins | 6 | 1999 | 314 | 0.600 |
Why?
| | Circular Dichroism | 17 | 2014 | 135 | 0.580 |
Why?
| | Protein Denaturation | 14 | 2015 | 68 | 0.580 |
Why?
| | Antibodies, Viral | 4 | 2023 | 522 | 0.570 |
Why?
| | Protein Structure, Tertiary | 15 | 2015 | 797 | 0.570 |
Why?
| | Solutions | 15 | 2015 | 146 | 0.560 |
Why?
| | Scattering, Radiation | 10 | 2012 | 92 | 0.560 |
Why?
| | Complement System Proteins | 1 | 2019 | 285 | 0.550 |
Why?
| | Polyesters | 6 | 2004 | 64 | 0.550 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 132 | 0.550 |
Why?
| | Spectrophotometry, Infrared | 13 | 2014 | 43 | 0.540 |
Why?
| | Calorimetry, Differential Scanning | 9 | 2015 | 34 | 0.540 |
Why?
| | Buffers | 11 | 2014 | 53 | 0.540 |
Why?
| | Humans | 76 | 2023 | 114937 | 0.530 |
Why?
| | Aluminum Oxide | 2 | 2022 | 11 | 0.520 |
Why?
| | Rheology | 6 | 2019 | 86 | 0.520 |
Why?
| | Escherichia coli | 4 | 2022 | 722 | 0.510 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 243 | 0.510 |
Why?
| | Chromatography, High Pressure Liquid | 10 | 2016 | 474 | 0.510 |
Why?
| | Powders | 5 | 2022 | 38 | 0.510 |
Why?
| | Databases, Factual | 2 | 2017 | 1125 | 0.510 |
Why?
| | Oncogene Proteins, Viral | 1 | 2015 | 20 | 0.500 |
Why?
| | Ovalbumin | 1 | 2015 | 162 | 0.490 |
Why?
| | Models, Chemical | 6 | 2012 | 250 | 0.490 |
Why?
| | Anthrax Vaccines | 1 | 2015 | 7 | 0.490 |
Why?
| | Crystallization | 8 | 2019 | 136 | 0.490 |
Why?
| | Interferon-gamma | 4 | 2003 | 723 | 0.480 |
Why?
| | Lipid A | 1 | 2015 | 27 | 0.480 |
Why?
| | Serum Albumin, Bovine | 3 | 2015 | 62 | 0.480 |
Why?
| | Polyethylene Glycols | 10 | 2014 | 561 | 0.470 |
Why?
| | Light | 10 | 2012 | 336 | 0.470 |
Why?
| | Kinetics | 16 | 2010 | 1555 | 0.460 |
Why?
| | Pharmaceutical Preparations | 4 | 2018 | 169 | 0.440 |
Why?
| | Ricin | 1 | 2013 | 8 | 0.440 |
Why?
| | Guanidine | 9 | 2014 | 18 | 0.440 |
Why?
| | Preservatives, Pharmaceutical | 2 | 2011 | 24 | 0.430 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2012 | 666 | 0.430 |
Why?
| | Mice, Inbred C57BL | 10 | 2017 | 4719 | 0.430 |
Why?
| | Polymers | 4 | 2004 | 447 | 0.430 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 5 | 2015 | 319 | 0.430 |
Why?
| | Stainless Steel | 2 | 2010 | 21 | 0.420 |
Why?
| | Streptavidin | 2 | 2009 | 15 | 0.420 |
Why?
| | Vaccines, Subunit | 1 | 2013 | 42 | 0.420 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 9 | 2011 | 76 | 0.420 |
Why?
| | Drug Delivery Systems | 6 | 2011 | 296 | 0.420 |
Why?
| | Antigens | 3 | 2009 | 318 | 0.420 |
Why?
| | Hydroxyethyl Starch Derivatives | 3 | 2009 | 7 | 0.420 |
Why?
| | Protein Binding | 16 | 2018 | 1897 | 0.410 |
Why?
| | Histidine | 2 | 2011 | 57 | 0.410 |
Why?
| | Peptides | 1 | 2018 | 848 | 0.410 |
Why?
| | Vaccines, Synthetic | 3 | 2009 | 125 | 0.410 |
Why?
| | Enzyme Stability | 5 | 2009 | 62 | 0.400 |
Why?
| | Chemical Precipitation | 8 | 2009 | 38 | 0.400 |
Why?
| | Deuterium Exchange Measurement | 2 | 2011 | 29 | 0.400 |
Why?
| | Chromatography, Affinity | 1 | 2011 | 81 | 0.390 |
Why?
| | Ultraviolet Rays | 2 | 2014 | 366 | 0.390 |
Why?
| | Transition Temperature | 5 | 2014 | 26 | 0.380 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 221 | 0.380 |
Why?
| | Static Electricity | 4 | 2020 | 114 | 0.370 |
Why?
| | Abatacept | 4 | 2012 | 40 | 0.370 |
Why?
| | Urea | 7 | 2018 | 68 | 0.350 |
Why?
| | Ribonuclease, Pancreatic | 2 | 2009 | 11 | 0.350 |
Why?
| | Methionine | 3 | 2012 | 144 | 0.340 |
Why?
| | Lactic Acid | 4 | 2011 | 275 | 0.340 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2009 | 35 | 0.340 |
Why?
| | Tungsten | 1 | 2009 | 26 | 0.340 |
Why?
| | Pressure | 7 | 2009 | 218 | 0.340 |
Why?
| | Microscopy, Electron, Transmission | 3 | 2021 | 135 | 0.330 |
Why?
| | Trastuzumab | 3 | 2019 | 89 | 0.330 |
Why?
| | Cellulase | 2 | 2006 | 30 | 0.320 |
Why?
| | Botulinum Toxins | 4 | 2010 | 39 | 0.320 |
Why?
| | Aluminum | 1 | 2008 | 34 | 0.320 |
Why?
| | Pharmaceutical Solutions | 6 | 2014 | 14 | 0.310 |
Why?
| | Albumins | 3 | 2013 | 89 | 0.310 |
Why?
| | Viscosity | 4 | 2018 | 81 | 0.310 |
Why?
| | Mass Spectrometry | 4 | 2010 | 633 | 0.310 |
Why?
| | Carbon Dioxide | 2 | 2004 | 218 | 0.310 |
Why?
| | DNA | 3 | 2023 | 1351 | 0.310 |
Why?
| | Alkaline Phosphatase | 1 | 2009 | 143 | 0.300 |
Why?
| | Hot Temperature | 7 | 2018 | 304 | 0.300 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 648 | 0.300 |
Why?
| | Interferon-alpha | 3 | 2013 | 187 | 0.290 |
Why?
| | Nanostructures | 3 | 2005 | 96 | 0.290 |
Why?
| | Microscopy, Electron, Scanning | 8 | 2005 | 192 | 0.280 |
Why?
| | Macrophages, Alveolar | 3 | 2006 | 351 | 0.280 |
Why?
| | Flow Cytometry | 1 | 2010 | 1087 | 0.280 |
Why?
| | Anilino Naphthalenesulfonates | 4 | 2018 | 10 | 0.280 |
Why?
| | Protein Biosynthesis | 1 | 2009 | 385 | 0.280 |
Why?
| | Protein Unfolding | 4 | 2019 | 31 | 0.280 |
Why?
| | Oils | 2 | 2018 | 19 | 0.280 |
Why?
| | Chickens | 5 | 2017 | 177 | 0.270 |
Why?
| | Filtration | 3 | 2014 | 59 | 0.270 |
Why?
| | Surface Tension | 2 | 2023 | 8 | 0.270 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2010 | 138 | 0.260 |
Why?
| | Griseofulvin | 1 | 2005 | 2 | 0.260 |
Why?
| | Decanoic Acids | 1 | 2005 | 7 | 0.260 |
Why?
| | Anhydrides | 1 | 2005 | 18 | 0.260 |
Why?
| | Female | 15 | 2021 | 59581 | 0.260 |
Why?
| | Immunogenetic Phenomena | 2 | 2016 | 6 | 0.250 |
Why?
| | Subtilisins | 2 | 2005 | 9 | 0.250 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2005 | 21 | 0.250 |
Why?
| | Amyloidosis | 2 | 2002 | 36 | 0.240 |
Why?
| | Injections, Subcutaneous | 2 | 2016 | 134 | 0.240 |
Why?
| | Trypsin Inhibitor, Kunitz Soybean | 1 | 2004 | 1 | 0.240 |
Why?
| | Protein Structure, Quaternary | 4 | 2011 | 115 | 0.240 |
Why?
| | Bacterial Vaccines | 3 | 2009 | 61 | 0.240 |
Why?
| | Platelet Aggregation | 1 | 2005 | 94 | 0.240 |
Why?
| | Cattle | 6 | 2015 | 924 | 0.230 |
Why?
| | Desiccation | 2 | 2021 | 17 | 0.220 |
Why?
| | Vitreous Body | 2 | 2003 | 101 | 0.220 |
Why?
| | Fibroblast Growth Factor 10 | 2 | 2013 | 24 | 0.210 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2003 | 165 | 0.210 |
Why?
| | Dimerization | 7 | 2014 | 176 | 0.210 |
Why?
| | Disaccharides | 3 | 2013 | 16 | 0.210 |
Why?
| | Diffusion | 3 | 2016 | 118 | 0.210 |
Why?
| | Vaccines, DNA | 1 | 2002 | 30 | 0.210 |
Why?
| | Peroxides | 1 | 2022 | 20 | 0.200 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 429 | 0.200 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2019 | 125 | 0.200 |
Why?
| | Gentamicins | 2 | 1998 | 42 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 1856 | 0.190 |
Why?
| | Metals | 2 | 2013 | 107 | 0.190 |
Why?
| | Tryptophan | 3 | 2013 | 135 | 0.190 |
Why?
| | Primates | 1 | 2022 | 111 | 0.190 |
Why?
| | Coloring Agents | 2 | 2002 | 72 | 0.190 |
Why?
| | Subtilisin | 1 | 2000 | 3 | 0.190 |
Why?
| | Mannitol | 3 | 2019 | 32 | 0.180 |
Why?
| | Laboratories | 1 | 2021 | 95 | 0.180 |
Why?
| | Dextrans | 7 | 2000 | 74 | 0.180 |
Why?
| | Time Factors | 8 | 2021 | 6125 | 0.180 |
Why?
| | Isoniazid | 3 | 2006 | 52 | 0.180 |
Why?
| | High-Throughput Screening Assays | 1 | 2022 | 123 | 0.180 |
Why?
| | Models, Molecular | 4 | 2016 | 1379 | 0.180 |
Why?
| | Immunization | 1 | 2023 | 402 | 0.180 |
Why?
| | Silicon Dioxide | 2 | 2015 | 88 | 0.180 |
Why?
| | Solvents | 4 | 2004 | 105 | 0.170 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 797 | 0.170 |
Why?
| | Elasticity | 2 | 2018 | 190 | 0.170 |
Why?
| | Structure-Activity Relationship | 4 | 2011 | 503 | 0.170 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1700 | 0.170 |
Why?
| | beta-Lactamases | 1 | 1999 | 26 | 0.170 |
Why?
| | Complement C5a | 1 | 2019 | 59 | 0.170 |
Why?
| | Complement C4a | 1 | 2019 | 6 | 0.170 |
Why?
| | Plasticizers | 1 | 2019 | 12 | 0.170 |
Why?
| | Algorithms | 3 | 2020 | 1474 | 0.170 |
Why?
| | Electron Spin Resonance Spectroscopy | 7 | 2000 | 86 | 0.160 |
Why?
| | Complement C3a | 1 | 2019 | 33 | 0.160 |
Why?
| | Thromboplastin | 1 | 1999 | 71 | 0.160 |
Why?
| | Pharmaceutic Aids | 1 | 1998 | 1 | 0.160 |
Why?
| | Complement Factor B | 1 | 2019 | 100 | 0.160 |
Why?
| | Complement C3 | 1 | 2019 | 189 | 0.160 |
Why?
| | Tandem Mass Spectrometry | 2 | 2014 | 413 | 0.160 |
Why?
| | Calibration | 1 | 2018 | 125 | 0.150 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 2018 | 22 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2011 | 473 | 0.150 |
Why?
| | Microscopy, Fluorescence | 2 | 2018 | 398 | 0.150 |
Why?
| | Oxidation-Reduction | 6 | 2012 | 927 | 0.150 |
Why?
| | Photolysis | 2 | 2018 | 79 | 0.150 |
Why?
| | Dosage Forms | 1 | 1997 | 10 | 0.150 |
Why?
| | Crystallography, X-Ray | 2 | 2009 | 405 | 0.150 |
Why?
| | Software | 1 | 2021 | 537 | 0.150 |
Why?
| | Optical Imaging | 1 | 2018 | 54 | 0.150 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 63 | 0.140 |
Why?
| | Immune Tolerance | 2 | 2017 | 328 | 0.140 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 4 | 2019 | 176 | 0.140 |
Why?
| | Mice, Transgenic | 3 | 2017 | 1953 | 0.140 |
Why?
| | Quaternary Ammonium Compounds | 3 | 2006 | 44 | 0.140 |
Why?
| | Suspensions | 1 | 2016 | 30 | 0.140 |
Why?
| | Viscoelastic Substances | 1 | 2016 | 9 | 0.140 |
Why?
| | Immunoproteins | 1 | 2016 | 1 | 0.130 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2017 | 70 | 0.130 |
Why?
| | Sodium Dodecyl Sulfate | 2 | 2006 | 21 | 0.130 |
Why?
| | Electrochemistry | 4 | 2016 | 79 | 0.130 |
Why?
| | Spectrophotometry, Ultraviolet | 6 | 2014 | 74 | 0.130 |
Why?
| | Neutralization Tests | 1 | 2015 | 63 | 0.130 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2014 | 162 | 0.120 |
Why?
| | Erythropoietin | 1 | 2015 | 72 | 0.120 |
Why?
| | Cresols | 1 | 2014 | 4 | 0.120 |
Why?
| | Cricetinae | 2 | 2012 | 254 | 0.120 |
Why?
| | Phenol | 1 | 2014 | 18 | 0.120 |
Why?
| | Calorimetry | 2 | 2008 | 60 | 0.120 |
Why?
| | Models, Animal | 1 | 2016 | 346 | 0.120 |
Why?
| | Micropore Filters | 1 | 2014 | 6 | 0.120 |
Why?
| | Insulin Lispro | 1 | 2014 | 35 | 0.120 |
Why?
| | Insulin Aspart | 1 | 2014 | 26 | 0.120 |
Why?
| | Models, Theoretical | 1 | 2018 | 516 | 0.120 |
Why?
| | Parvovirus | 1 | 2014 | 13 | 0.120 |
Why?
| | Biofouling | 1 | 2014 | 7 | 0.110 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2014 | 26 | 0.110 |
Why?
| | Cross Reactions | 1 | 2014 | 117 | 0.110 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2014 | 128 | 0.110 |
Why?
| | Delayed-Action Preparations | 4 | 2011 | 159 | 0.110 |
Why?
| | Immunoglobulin Light Chains | 3 | 2003 | 35 | 0.110 |
Why?
| | In Vitro Techniques | 4 | 2005 | 1034 | 0.110 |
Why?
| | Lactates | 1 | 1993 | 79 | 0.110 |
Why?
| | Ferrous Compounds | 1 | 2013 | 22 | 0.110 |
Why?
| | Silicates | 1 | 2012 | 11 | 0.110 |
Why?
| | Epitopes | 1 | 2015 | 436 | 0.110 |
Why?
| | Silicones | 1 | 2012 | 20 | 0.110 |
Why?
| | Boron Compounds | 1 | 2012 | 17 | 0.110 |
Why?
| | Sodium Chloride | 4 | 2013 | 136 | 0.110 |
Why?
| | Isoenzymes | 2 | 2001 | 285 | 0.100 |
Why?
| | Trace Elements | 1 | 2013 | 45 | 0.100 |
Why?
| | X-Ray Diffraction | 2 | 2005 | 84 | 0.100 |
Why?
| | Mice, Nude | 1 | 2014 | 635 | 0.100 |
Why?
| | Antitubercular Agents | 2 | 2005 | 169 | 0.100 |
Why?
| | Carbonic Anhydrases | 1 | 1992 | 13 | 0.100 |
Why?
| | Rats | 4 | 2010 | 4963 | 0.100 |
Why?
| | Weight Gain | 2 | 2013 | 451 | 0.100 |
Why?
| | Spectrum Analysis | 3 | 2008 | 81 | 0.100 |
Why?
| | Phospholipids | 1 | 2013 | 197 | 0.100 |
Why?
| | Polystyrenes | 1 | 2011 | 36 | 0.100 |
Why?
| | Biopharmaceutics | 1 | 2011 | 2 | 0.100 |
Why?
| | Interferon-beta | 1 | 2011 | 79 | 0.090 |
Why?
| | Carbohydrates | 4 | 2013 | 56 | 0.090 |
Why?
| | Binding Sites | 3 | 2011 | 1176 | 0.090 |
Why?
| | Salts | 2 | 2008 | 36 | 0.090 |
Why?
| | Hypophysectomy | 1 | 2010 | 15 | 0.090 |
Why?
| | Fermentation | 1 | 2010 | 21 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2009 | 1988 | 0.090 |
Why?
| | Chromatography, Ion Exchange | 1 | 2010 | 48 | 0.090 |
Why?
| | beta-Cyclodextrins | 1 | 2010 | 28 | 0.090 |
Why?
| | Tungsten Compounds | 1 | 2009 | 3 | 0.090 |
Why?
| | Steel | 1 | 2009 | 7 | 0.090 |
Why?
| | Aluminum Compounds | 1 | 2009 | 6 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 3 | 2010 | 2211 | 0.080 |
Why?
| | Microscopy, Atomic Force | 1 | 2010 | 113 | 0.080 |
Why?
| | Phase Transition | 1 | 2009 | 25 | 0.080 |
Why?
| | Molecular Sequence Data | 3 | 2009 | 2791 | 0.080 |
Why?
| | Oxides | 1 | 2009 | 43 | 0.080 |
Why?
| | Bacteriophage T4 | 1 | 2009 | 15 | 0.080 |
Why?
| | Factor XIII | 2 | 1998 | 7 | 0.080 |
Why?
| | Clostridium botulinum | 1 | 2008 | 4 | 0.080 |
Why?
| | Immunization, Secondary | 1 | 2009 | 82 | 0.080 |
Why?
| | Powder Diffraction | 1 | 2008 | 2 | 0.080 |
Why?
| | Ultracentrifugation | 3 | 2009 | 48 | 0.080 |
Why?
| | Biodegradation, Environmental | 2 | 2002 | 80 | 0.080 |
Why?
| | Succinates | 1 | 2008 | 18 | 0.080 |
Why?
| | Protein Multimerization | 1 | 2009 | 159 | 0.080 |
Why?
| | Protein Renaturation | 2 | 2005 | 4 | 0.080 |
Why?
| | Molecular Structure | 2 | 2006 | 438 | 0.080 |
Why?
| | Chemical Phenomena | 3 | 2014 | 81 | 0.070 |
Why?
| | Nanotechnology | 1 | 2009 | 113 | 0.070 |
Why?
| | Micelles | 2 | 2005 | 34 | 0.070 |
Why?
| | Immunoglobulin E | 1 | 2009 | 317 | 0.070 |
Why?
| | Molecular Conformation | 1 | 2007 | 138 | 0.070 |
Why?
| | Fractionation, Field Flow | 1 | 2007 | 3 | 0.070 |
Why?
| | Hydrogen | 3 | 2003 | 60 | 0.070 |
Why?
| | Actins | 2 | 2000 | 382 | 0.070 |
Why?
| | Deuterium | 3 | 2003 | 79 | 0.070 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2008 | 238 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2014 | 1008 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2014 | 1749 | 0.070 |
Why?
| | Congo Red | 2 | 2003 | 8 | 0.070 |
Why?
| | Poliomyelitis | 2 | 2018 | 27 | 0.070 |
Why?
| | Dithiothreitol | 1 | 2005 | 17 | 0.070 |
Why?
| | Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.070 |
Why?
| | Biometry | 1 | 2006 | 63 | 0.070 |
Why?
| | Glutathione Disulfide | 1 | 2005 | 26 | 0.070 |
Why?
| | Bacillus | 1 | 2005 | 14 | 0.070 |
Why?
| | alpha-Amylases | 1 | 2005 | 16 | 0.060 |
Why?
| | Trichoderma | 1 | 2005 | 24 | 0.060 |
Why?
| | Detergents | 1 | 2005 | 41 | 0.060 |
Why?
| | Immunoglobulin Variable Region | 2 | 2003 | 72 | 0.060 |
Why?
| | Receptors, Interleukin-1 | 3 | 2005 | 227 | 0.060 |
Why?
| | Disulfides | 1 | 2005 | 90 | 0.060 |
Why?
| | Cell Line | 3 | 2006 | 2640 | 0.060 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2004 | 47 | 0.060 |
Why?
| | Arginine | 1 | 2005 | 237 | 0.060 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 323 | 0.060 |
Why?
| | Models, Biological | 2 | 2003 | 1630 | 0.060 |
Why?
| | Interleukin-11 | 1 | 2004 | 9 | 0.060 |
Why?
| | Fluorescence | 3 | 2013 | 148 | 0.060 |
Why?
| | Male | 5 | 2017 | 55663 | 0.060 |
Why?
| | Nucleic Acid Conformation | 1 | 2007 | 669 | 0.060 |
Why?
| | Methods | 1 | 2002 | 58 | 0.050 |
Why?
| | Models, Statistical | 1 | 2006 | 604 | 0.050 |
Why?
| | Time | 1 | 2002 | 70 | 0.050 |
Why?
| | Tyrosine | 1 | 2003 | 216 | 0.050 |
Why?
| | Prodrugs | 1 | 2002 | 42 | 0.050 |
Why?
| | Drug Interactions | 2 | 2004 | 347 | 0.050 |
Why?
| | L-Selectin | 1 | 2001 | 25 | 0.050 |
Why?
| | RNA | 1 | 2007 | 810 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2001 | 107 | 0.050 |
Why?
| | Borates | 1 | 2000 | 3 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2003 | 536 | 0.050 |
Why?
| | Chemistry, Physical | 2 | 1997 | 37 | 0.050 |
Why?
| | Drug Design | 1 | 2002 | 151 | 0.050 |
Why?
| | Myoglobin | 1 | 2000 | 14 | 0.050 |
Why?
| | Cytochrome c Group | 1 | 2000 | 36 | 0.050 |
Why?
| | Nerve Growth Factor | 1 | 2000 | 27 | 0.050 |
Why?
| | Free Radical Scavengers | 1 | 2000 | 78 | 0.050 |
Why?
| | Electric Conductivity | 1 | 2000 | 88 | 0.040 |
Why?
| | Bence Jones Protein | 1 | 2000 | 1 | 0.040 |
Why?
| | Permeability | 1 | 2000 | 148 | 0.040 |
Why?
| | Calcium | 1 | 2005 | 1104 | 0.040 |
Why?
| | Bacteria | 1 | 2006 | 728 | 0.040 |
Why?
| | Hydrogels | 2 | 2021 | 573 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 1999 | 10 | 0.040 |
Why?
| | Quality Control | 2 | 2010 | 144 | 0.040 |
Why?
| | Mitosporic Fungi | 1 | 1999 | 7 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2003 | 529 | 0.040 |
Why?
| | Refractometry | 1 | 1999 | 27 | 0.040 |
Why?
| | Parkinson Disease | 1 | 2003 | 323 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2022 | 2770 | 0.040 |
Why?
| | Lipase | 1 | 1999 | 57 | 0.040 |
Why?
| | Computer Simulation | 1 | 2003 | 880 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1999 | 119 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 1999 | 200 | 0.040 |
Why?
| | Centrifugation | 1 | 2018 | 31 | 0.040 |
Why?
| | Copper | 1 | 1999 | 100 | 0.040 |
Why?
| | Phosphates | 2 | 2010 | 158 | 0.040 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 1999 | 106 | 0.040 |
Why?
| | Zinc | 1 | 2000 | 257 | 0.040 |
Why?
| | Interferons | 1 | 1998 | 151 | 0.040 |
Why?
| | Pregnancy | 1 | 2009 | 5527 | 0.040 |
Why?
| | Potassium Chloride | 1 | 1997 | 35 | 0.040 |
Why?
| | Self Administration | 1 | 2018 | 123 | 0.040 |
Why?
| | Proteolysis | 1 | 2018 | 143 | 0.040 |
Why?
| | Povidone | 1 | 1996 | 5 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 281 | 0.030 |
Why?
| | Epoetin Alfa | 1 | 2015 | 6 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 547 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 369 | 0.030 |
Why?
| | Isoelectric Point | 1 | 2014 | 22 | 0.030 |
Why?
| | Rabbits | 3 | 2001 | 748 | 0.030 |
Why?
| | Horses | 3 | 2003 | 96 | 0.030 |
Why?
| | Hypodermoclysis | 1 | 2013 | 4 | 0.030 |
Why?
| | Kidney | 1 | 2001 | 1184 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 2013 | 100 | 0.030 |
Why?
| | Acrylamides | 1 | 2013 | 42 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2013 | 201 | 0.030 |
Why?
| | Sulfites | 1 | 2013 | 4 | 0.030 |
Why?
| | Poliovirus | 1 | 2013 | 77 | 0.030 |
Why?
| | Cold Temperature | 1 | 2014 | 128 | 0.030 |
Why?
| | Lung | 1 | 2005 | 3593 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2013 | 176 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 133 | 0.030 |
Why?
| | Iodides | 1 | 1992 | 6 | 0.030 |
Why?
| | Particulate Matter | 1 | 2013 | 185 | 0.030 |
Why?
| | Guanidines | 1 | 1992 | 33 | 0.030 |
Why?
| | Absorption | 2 | 2004 | 52 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 2003 | 410 | 0.020 |
Why?
| | Heparin | 1 | 2013 | 222 | 0.020 |
Why?
| | Polyglycolic Acid | 1 | 2011 | 43 | 0.020 |
Why?
| | Interferon beta-1a | 1 | 2011 | 12 | 0.020 |
Why?
| | Injections | 1 | 2011 | 159 | 0.020 |
Why?
| | 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2010 | 6 | 0.020 |
Why?
| | Clostridium | 1 | 2009 | 14 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 582 | 0.020 |
Why?
| | Consumer Product Safety | 1 | 2009 | 30 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 1998 | 1477 | 0.020 |
Why?
| | Equipment Design | 1 | 2011 | 511 | 0.020 |
Why?
| | Deuterium Oxide | 2 | 1999 | 13 | 0.020 |
Why?
| | Cholesterol Oxidase | 1 | 1988 | 1 | 0.020 |
Why?
| | Spores, Bacterial | 1 | 2008 | 19 | 0.020 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1988 | 9 | 0.020 |
Why?
| | Alcohol Dehydrogenase | 1 | 1988 | 16 | 0.020 |
Why?
| | Rosaniline Dyes | 1 | 2007 | 10 | 0.020 |
Why?
| | Enzymes, Immobilized | 1 | 1988 | 25 | 0.020 |
Why?
| | Peptide Mapping | 1 | 2007 | 60 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2007 | 99 | 0.020 |
Why?
| | Enzymes | 1 | 1988 | 62 | 0.020 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2005 | 9 | 0.020 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2005 | 10 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2007 | 169 | 0.020 |
Why?
| | Prions | 1 | 2006 | 33 | 0.020 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2005 | 64 | 0.020 |
Why?
| | Oxidants | 1 | 2006 | 112 | 0.020 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2004 | 25 | 0.020 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2005 | 147 | 0.020 |
Why?
| | Ultrafiltration | 1 | 2004 | 27 | 0.010 |
Why?
| | Molecular Weight | 1 | 2004 | 332 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 2005 | 163 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 2005 | 191 | 0.010 |
Why?
| | Base Sequence | 1 | 2007 | 2118 | 0.010 |
Why?
| | Ribonucleases | 1 | 2003 | 52 | 0.010 |
Why?
| | Synucleins | 1 | 2003 | 5 | 0.010 |
Why?
| | Cytochromes c | 1 | 2003 | 63 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2005 | 590 | 0.010 |
Why?
| | alpha-Synuclein | 1 | 2003 | 21 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2003 | 28 | 0.010 |
Why?
| | Ions | 1 | 2002 | 59 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 2003 | 181 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2003 | 262 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 110 | 0.010 |
Why?
| | Biological Transport | 1 | 2003 | 372 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2005 | 696 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2003 | 339 | 0.010 |
Why?
| | Sorbitol | 1 | 2001 | 15 | 0.010 |
Why?
| | Betaine | 1 | 2001 | 63 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2002 | 642 | 0.010 |
Why?
| | Protein Subunits | 1 | 2001 | 201 | 0.010 |
Why?
| | Chromatography | 1 | 2000 | 23 | 0.010 |
Why?
| | Muscles | 1 | 2001 | 322 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 790 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2000 | 353 | 0.010 |
Why?
| | Hydrogen Bonding | 1 | 1999 | 143 | 0.010 |
Why?
| | Swine | 1 | 2001 | 701 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2001 | 425 | 0.010 |
Why?
| | Drug Carriers | 1 | 1998 | 112 | 0.010 |
Why?
| | Osteomyelitis | 1 | 1998 | 102 | 0.010 |
Why?
| | Lactose | 1 | 1996 | 6 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2003 | 1084 | 0.010 |
Why?
| | Middle Aged | 1 | 1996 | 26806 | 0.010 |
Why?
| | Cysteine | 1 | 1997 | 171 | 0.010 |
Why?
| | Myocardium | 1 | 2001 | 911 | 0.010 |
Why?
| | Fructose | 1 | 1996 | 100 | 0.010 |
Why?
| | Cyclic N-Oxides | 1 | 1995 | 30 | 0.010 |
Why?
| | Spin Labels | 1 | 1995 | 44 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2000 | 5035 | 0.010 |
Why?
| | Liver | 1 | 1988 | 1634 | 0.000 |
Why?
|
|
Randolph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|